Open Insider Trading Activity for Akero Therapeutics, Inc. President and CEO Cheng Andrew
31-day price and insider activity (up to 2 years)
Daily candles with triangles for the buy and sale transactions shown below. Scroll left or zoom out to load earlier candles (up to 2 years).
▲ Insider buy
▼ Insider sale
Loading daily price history…
Charting by TradingView Lightweight Charts
| Ticker | Filing Date | Transaction Date | Company | Insider | Title | Transaction | Trade Count | Shares | Avg. Price | Total Value | Position Size Change | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10b5-1: Scheduled Form 4 Transaction AKRO | 2025-10-14 | 2025-10-10 | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | Sell | 1 | 30,000 | $53.98 | $1,619,400.00 | 5.39% | View Filing |
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting AKRO | 2025-06-20 | 2025-06-18 | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | Sell | 1 | 6,620 | $54.84 | $363,040.80 | 1.19% | View Filing |